Revolution Medicines, Inc.(RVMD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RVMD Revolution Medicines, Inc.

休市中 05-17 16:00:00 EDT

39.41

+0.42

+1.08%

盘后39.41

+0.000.00%

16:58 EDT

最高39.80	最低38.70	成交量111.83万
今开39.38	昨收38.99	日振幅2.82%
总市值65.02亿	流通市值63.51亿	总股本1.65亿
成交额4,396万	换手率0.69%	流通股本1.61亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"RVMD","market":"US","secType":"STK","nameCN":"Revolution Medicines, Inc.","latestPrice":39.41,"timestamp":1715976000000,"preClose":38.99,"halted":0,"volume":1118299,"hourTrading":{"tag":"盘后","latestPrice":39.41,"preClose":39.41,"latestTime":"16:58 EDT","volume":58347,"amount":2299390.48,"timestamp":1715979490221},"delay":0,"floatShares":161161532,"shares":164986227,"eps":-3.710366,"marketStatus":"休市中","marketStatusCode":7,"change":0.42,"latestTime":"05-17 16:00:00 EDT","open":39.38,"high":39.8,"low":38.7,"amount":43964704.002491996,"amplitude":0.028212,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.710366,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1716192000000},"adr":0,"listingDate":1581570000000,"adjPreClose":38.99,"preHourTrading":{"tag":"盘前","latestPrice":39.99,"preClose":38.99,"latestTime":"08:06 EDT","volume":79,"amount":3159.720024,"timestamp":1715947589983},"postHourTrading":{"tag":"盘后","latestPrice":39.41,"preClose":39.41,"latestTime":"16:58 EDT","volume":58347,"amount":2299390.48,"timestamp":1715979490221},"volumeRatio":0.9703657682962787},"requestUrl":"/m/hq/s/RVMD","defaultTab":"news","newsList":[{"id":"2436945413","title":"Revolution Medicines, Inc.2024财年第一财季实现净利润-1.16亿美元，同比减少70.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436945413","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2436945413?lang=zh_cn&edition=full","pubTime":"2024-05-18 00:18","pubTimestamp":1715962731,"startTime":"0","endTime":"0","summary":"3月31日，Revolution Medicines, Inc.公布财报，公告显示公司2024财年第一财季净利润为-1.16亿美元，同比减少70.34%；其中营业收入为0.00美元，每股基本收益为-0.70美元。从资产负债表来看，Revolution Medicines, Inc.总负债1.83亿美元，其中短期债务8.17百万美元，资产负债比为10.43，流动比率为0.19。机构评级：截至2024年3月31日，当前有13家机构对Revolution Medicines, Inc.目标价做出预测，其中目标均价为45.01美元，其中最低目标价为40.00美元，最高目标价为50.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051800185887750962&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051800185887750962&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433252674","title":"Revolution Medicines Inc    预计每股亏损 75 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433252674","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2433252674?lang=zh_cn&edition=full","pubTime":"2024-05-07 08:01","pubTimestamp":1715040109,"startTime":"0","endTime":"0","summary":"   * Revolution Medicines Inc    将于5月8日公布截至2024年3月31日的财报，预计季度收入将出现下降。* 根据LSEG的数据，10位分析师的平均预期显示，这家总部位于加利福尼亚州红木城的公司的营收将从去年同期的701万美元下降79.5%，至144万美元。* LSEG 的分析师平均预计 Revolution Medicines Inc 每股亏损 75 美分。* 华尔街对Revolution Medicines Inc的12个月目标价中位数为42.50美元，高于其上次收盘价39.05美元。5月7日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2426762202","title":"美国研究综述-Cheesecake Factory、Netflix、Texas Roadhouse","url":"https://stock-news.laohu8.com/highlight/detail?id=2426762202","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2426762202?lang=zh_cn&edition=full","pubTime":"2024-04-12 15:04","pubTimestamp":1712905476,"startTime":"0","endTime":"0","summary":"    路透社4月12日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，其中包括 Cheesecake Factory、Netflix 和 Texas Roadhouse。要闻             * Cheesecake Factory Inc   ：斯蒂芬斯恢复覆盖，给予增持评级             * Netflix Inc   ：Piper Sandler将目标价从550美元上调至600美元             * Texas Roadhouse Inc   ：斯蒂芬斯恢复对该公司的研究，给予等权重评级 以下是路透社周五报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2426445828","title":"雷蒙德詹姆斯公司：上调Revolution Medicines(RVMD.US)评级，由优于大市调整至强烈买入评级, 目标价由36.00美元调整至48.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2426445828","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426445828?lang=zh_cn&edition=full","pubTime":"2024-04-11 01:24","pubTimestamp":1712769895,"startTime":"0","endTime":"0","summary":"雷蒙德詹姆斯公司：上调Revolution Medicines(RVMD.US)评级，由优于大市调整至强烈买入评级, 目标价由36.00美元调整至48.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404110124588b0b69a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404110124588b0b69a5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426418921","title":"BUZZ-雷蒙德-詹姆斯（Raymond James）将 Revolution Medicines 的评级提升为 \"强力买入\"，该公司股价大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2426418921","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2426418921?lang=zh_cn&edition=full","pubTime":"2024-04-10 22:30","pubTimestamp":1712759400,"startTime":"0","endTime":"0","summary":"    4月10日 - ** 生物技术公司Revolution Medicines   股价上涨9%，报36.09美元** 雷蒙德-詹姆斯将其评级从 \"跑赢大盘 \"上调至 \"强力买入\"，将目标价从36美元上调至48美元。** 该公司在同行评审期刊上发表了候选药物RMC-6236治疗非小细胞肺癌 和胰腺导管腺癌 的数据，这是一种胰腺癌。** 经纪公司称，这些数据使其更加确信 RVMD 可能拥有 \"众多具有同类最佳潜力的大片产品\"。** Raymond James 目前预测，RMC-6236 在 PDAC 和 NSCLC 领域的应用将在 2035 年全年带来约 49 亿美元的收入。** 股价年内上涨 25","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2426549172","title":"Revolution Medicines, Inc.盘中异动 早盘股价大涨5.56%报34.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426549172","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426549172?lang=zh_cn&edition=full","pubTime":"2024-04-10 21:33","pubTimestamp":1712756019,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日21时33分，Revolution Medicines, Inc.股票出现异动，股价快速拉升5.56%。截至发稿，该股报34.83美元/股，成交量8.3579万股，换手率0.05%，振幅2.61%。Revolution Medicines, Inc.股票所在的生物技术行业中，整体跌幅为1.13%。Revolution Medicines, Inc.公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041021334087e7f490&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041021334087e7f490&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418554674","title":"Revolution Medicines, Inc.盘中异动 急速拉升5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2418554674","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418554674?lang=zh_cn&edition=full","pubTime":"2024-03-12 23:21","pubTimestamp":1710256895,"startTime":"0","endTime":"0","summary":"北京时间2024年03月12日23时21分，Revolution Medicines, Inc.股票出现波动，股价快速拉升5.01%。Revolution Medicines, Inc.股票所在的生物技术行业中，整体涨幅为1.03%。Revolution Medicines, Inc.公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。消息层面，截至23时21分，Revolution Medicines, Inc.股票正面舆情新闻比例25%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403122321367a4bfb07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403122321367a4bfb07&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416623802","title":"Revolution Medicines, Inc.2023财年实现净利润-4.36亿美元，同比减少75.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416623802","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416623802?lang=zh_cn&edition=full","pubTime":"2024-03-02 00:24","pubTimestamp":1709310299,"startTime":"0","endTime":"0","summary":"12月31日，Revolution Medicines, Inc.公布财报，公告显示公司2023财年净利润为-4.36亿美元，同比减少75.10%；其中营业收入为11.58百万美元，同比减少67.27%，每股基本收益为-3.86美元。从资产负债表来看，Revolution Medicines, Inc.总负债2.62亿美元，其中短期债务7.37百万美元，资产负债比为7.98，流动比率为13.05。机构评级：截至2023年12月31日，当前有10家机构对Revolution Medicines, Inc.目标价做出预测，其中目标均价为37.90美元，其中最低目标价为34.00美元，最高目标价为43.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030200250487d85e57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030200250487d85e57&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414808777","title":"Revolution Medicines Inc盘中异动 急速上涨5.07%报31.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2414808777","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414808777?lang=zh_cn&edition=full","pubTime":"2024-02-27 22:32","pubTimestamp":1709044321,"startTime":"0","endTime":"0","summary":"北京时间2024年02月27日22时32分，Revolution Medicines Inc股票出现异动，股价快速拉升5.07%。Revolution Medicines Inc股票所在的生物技术行业中，整体跌幅为0.28%。Revolution Medicines Inc公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402272232027a4752e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402272232027a4752e3&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.revmed.com","stockEarnings":[{"period":"1week","weight":0.058},{"period":"1month","weight":0.0703},{"period":"3month","weight":0.3355},{"period":"6month","weight":0.8476},{"period":"1year","weight":0.5528},{"period":"ytd","weight":0.3741}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0577},{"period":"3month","weight":0.0599},{"period":"6month","weight":0.1745},{"period":"1year","weight":0.2629},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Revolution Medicines, Inc.成立于2014年10月，是特拉华州的一家公司。该公司是一家临床阶段的精准肿瘤学公司，专注于开发靶向疗法，以抑制RAS成瘾癌症的前沿靶点。该公司拥有先进的基于结构的药物发现能力，其基础是深厚的化学生物学和癌症药理学知识以及创新的专有技术，能够创造适合非常规结合位点的小分子。该公司对癌症的遗传驱动因素和适应性耐药机制的了解，加上强大的药物发现和药物化学能力，指导建立了一个针对RAS通路和相关通路中的关键信号节点的深层管道。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.002389},{"month":2,"riseRate":0.75,"avgChangeRate":0.00657},{"month":3,"riseRate":0.6,"avgChangeRate":-0.008788},{"month":4,"riseRate":0.6,"avgChangeRate":0.034923},{"month":5,"riseRate":0.4,"avgChangeRate":-0.02954},{"month":6,"riseRate":1,"avgChangeRate":0.07742},{"month":7,"riseRate":0.25,"avgChangeRate":-0.048322},{"month":8,"riseRate":0.75,"avgChangeRate":0.101714},{"month":9,"riseRate":0.25,"avgChangeRate":-0.016205},{"month":10,"riseRate":0.5,"avgChangeRate":-0.079994},{"month":11,"riseRate":0.75,"avgChangeRate":0.181921},{"month":12,"riseRate":0.5,"avgChangeRate":0.014112}],"exchange":"NASDAQ","name":"Revolution Medicines, Inc.","nameEN":"Revolution Medicines, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Revolution Medicines, Inc.(RVMD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Revolution Medicines, Inc.(RVMD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Revolution Medicines, Inc.,RVMD,Revolution Medicines, Inc.股票,Revolution Medicines, Inc.股票老虎,Revolution Medicines, Inc.股票老虎国际,Revolution Medicines, Inc.行情,Revolution Medicines, Inc.股票行情,Revolution Medicines, Inc.股价,Revolution Medicines, Inc.股市,Revolution Medicines, Inc.股票价格,Revolution Medicines, Inc.股票交易,Revolution Medicines, Inc.股票购买,Revolution Medicines, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Revolution Medicines, Inc.(RVMD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Revolution Medicines, Inc.(RVMD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}